Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Mapping IPF helps identify geographic regions at higher risk for disease development

Jessica Shull, Oriol Jorba, Carla Lara, Miriam Olid, Maria Teresa Pay, Guadalupe Bermudo, Guillermo Suarez Curatin, Vanesa Vicens, Lurdes Planas, Jaume Bordas, Pilar Rivera Ortega, Maria Molina Molina, Crampid Group
European Respiratory Journal 2020 56: 1796; DOI: 10.1183/13993003.congress-2020.1796
Jessica Shull
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jess.shull@gmail.com
Oriol Jorba
2Earth Sciences Department, Barcelona Supercomputing Center, BSC, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla Lara
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Olid
2Earth Sciences Department, Barcelona Supercomputing Center, BSC, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Teresa Pay
2Earth Sciences Department, Barcelona Supercomputing Center, BSC, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guadalupe Bermudo
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo Suarez Curatin
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanesa Vicens
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lurdes Planas
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaume Bordas
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pilar Rivera Ortega
3Respiratory Department, Manchester University NHS Foundation Trust, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Molina Molina
1ILD Unit of Respiratory Department, Bellvitge University Hospital, IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Crampid Group
4CRAMPID, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background and Objective: The relationship between IPF development and environmental factors has not been elucidated. Air pollutants have been associated with exacerbating symptoms of IPF. We hypothesise that cross-analysing location of IPF cases and air pollution concentrations could lead to recognition of environmental risk factors.

Methods: We analysed epidemiological and clinical data from 503 IPF patients in the Observatory.IPF in Catalonia. We generated maps of the most relevant air pollutant PM2.5 from the last 10 years using data from the CALIOPE air quality forecast system and observational data.

Results: In 2018, the prevalence of IPF differed across provinces, ranging from 8.0 cases per 100,000 habitants in Barcelona to 2.0 cases per 100,000 habitants in Girona. PM2.5 presented great variabliity.The ratio of IPF was increased in specific areas of the same region. PM2.5 concentrations were higher in postal codes where there is more industry, traffic, and shipping. These areas present more aggregation of IPF cases (Figure 1).

Conclusion: The prevalence of IPF is higher in areas of elevated air PM2.5 concentration. We suggest that further study needs to be done with broader patient cohorts in specific geographic areas to compile a broader profile of what environmental factors may be involved in development of IPF and other lung diseases.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

  • Idiopathic pulmonary fibrosis
  • Air pollution
  • Experimental approaches

Footnotes

Cite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 1796.

This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2020
Previous
Back to top
Vol 56 Issue suppl 64 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mapping IPF helps identify geographic regions at higher risk for disease development
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mapping IPF helps identify geographic regions at higher risk for disease development
Jessica Shull, Oriol Jorba, Carla Lara, Miriam Olid, Maria Teresa Pay, Guadalupe Bermudo, Guillermo Suarez Curatin, Vanesa Vicens, Lurdes Planas, Jaume Bordas, Pilar Rivera Ortega, Maria Molina Molina, Crampid Group
European Respiratory Journal Sep 2020, 56 (suppl 64) 1796; DOI: 10.1183/13993003.congress-2020.1796

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Mapping IPF helps identify geographic regions at higher risk for disease development
Jessica Shull, Oriol Jorba, Carla Lara, Miriam Olid, Maria Teresa Pay, Guadalupe Bermudo, Guillermo Suarez Curatin, Vanesa Vicens, Lurdes Planas, Jaume Bordas, Pilar Rivera Ortega, Maria Molina Molina, Crampid Group
European Respiratory Journal Sep 2020, 56 (suppl 64) 1796; DOI: 10.1183/13993003.congress-2020.1796
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Association between FVC and mortality or survival in idiopathic pulmonary fibrosis: a systematic literature review
  • PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
  • Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma
Show more Idiopathic interstitial pneumonias

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society